NASDAQ:SNCE Science 37 (SNCE) Stock Price, News & Analysis → The Gold Grab of the Century (From Colonial Metals) (Ad) Free SNCE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$5.75▼$5.7550-Day Range$5.68▼$5.7552-Week Range$3.73▼$12.96VolumeN/AAverage Volume43,227 shsMarket Capitalization$34.33 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Get Science 37 alerts: Email Address Ad WealthPressIt’s now possible to know the win rate of every trade… BEFORE you take it! Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << About Science 37 Stock (NASDAQ:SNCE)Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. As of March 11, 2024, Science 37 Holdings, Inc. operates as a subsidiary of eMed, LLC.Read More Ad WealthPressIt’s now possible to know the win rate of every trade… BEFORE you take it! Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << SNCE Stock News HeadlinesApril 17, 2024 | markets.businessinsider.comScience 37 Provides Fully Consented Patients to Sites to Supplement EnrollmentApril 17, 2024 | globenewswire.comScience 37 Provides Fully Consented Patients to Sites to Supplement EnrollmentApril 26, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…March 12, 2024 | prnewswire.comeMed completes tender offer for all outstanding shares of Science 37February 27, 2024 | businesswire.comSCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCEFebruary 12, 2024 | finance.yahoo.comeMed commences tender offer for Science 37February 10, 2024 | businesswire.comSCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCEFebruary 10, 2024 | markets.businessinsider.comScience 37 Initiates Cost-Cutting, Workforce Reduction PlanApril 26, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…February 4, 2024 | morningstar.comScience 37 Holdings Inc SNCEFebruary 1, 2024 | benzinga.comScience 37 Hldgs Stock (NASDAQ:SNCE) Dividends: History, Yield and DatesJanuary 31, 2024 | stockhouse.comShareholder Alert: Ademi LLP investigates whether Science 37 Holdings, Inc. has obtained a Fair Price in its transaction with eMedJanuary 30, 2024 | msn.comScience 37 Issues Regulation FD Informational DisclosureJanuary 30, 2024 | msn.comScience 37 Announces Upcoming Merger Agreement ExecutionJanuary 30, 2024 | realmoney.thestreet.comScience 37 just downgraded at Craig-Hallum, here's whyJanuary 29, 2024 | stockhouse.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Science 37 Holdings, Inc. BuyoutJanuary 29, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Science 37 (SNCE), Avid Bioservices (CDMO)January 29, 2024 | benzinga.comCrude Oil Down Over 1%; Science 37 Holdings Shares Spike HigherJanuary 29, 2024 | tmcnet.comSNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Science 37 Holdings, Inc. Is Fair to ShareholdersJanuary 29, 2024 | finanznachrichten.deScience 37, Inc.: Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating EnrollmentJanuary 29, 2024 | marketwatch.comScience 37 Shares Rise on Deal to Be AcquiredDecember 28, 2023 | seekingalpha.comNDRA, LITM and SNCE among mid-day moversDecember 13, 2023 | investorplace.comSNCE Stock Earnings: Science 37 Hldgs Beats EPS, Beats Revenue for Q3 2023December 13, 2023 | investorplace.comSNCE Stock Earnings: Science 37 Hldgs Beats EPS, Beats Revenue for Q2 2023December 13, 2023 | investorplace.comSNCE Stock Earnings: Science 37 Hldgs Beats EPS, Beats Revenue for Q1 2023December 12, 2023 | finance.yahoo.comScience 37 Receives Top Honors in Everest PEAK Matrix®December 5, 2023 | finance.yahoo.comScience 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023See More Headlines Receive SNCE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Science 37 and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolNASDAQ:SNCE CUSIPN/A CIK1819113 Webwww.lifesciacquisition.com Phone984-377-3737FaxN/AEmployees460Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($21.40) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-50,990,000.00 Net Margins-206.86% Pretax Margin-207.00% Return on Equity-83.09% Return on Assets-61.58% Debt Debt-to-Equity RatioN/A Current Ratio4.17 Quick Ratio4.17 Sales & Book Value Annual Sales$60.26 million Price / Sales0.57 Cash FlowN/A Price / Cash FlowN/A Book Value$16.70 per share Price / Book0.34Miscellaneous Outstanding Shares5,970,000Free Float5,564,000Market Cap$34.33 million OptionableNot Optionable Beta0.55 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. David Coman (Age 54)CEO & Director Comp: $796.13kMs. Christine A. Pellizzari J.D. (Age 56)Chief Legal & Human Resources Officer and Secretary Comp: $521.58kMs. Darcy Forman (Age 48)Chief Delivery Officer Comp: $550.58kMr. Mike Zaranek (Age 53)Chief Financial Officer Irena LambridisVP and Head of Quality Assurance & ComplianceMs. Margie Gimbel KoomanVice President of Marketing & CommunicationsMr. Drew BustosChief Strategy & Marketing OfficerMr. Jonathan Cotliar M.D. (Age 52)Chief Medical Officer Comp: $486.6kMr. Michael Shipton (Age 52)Chief Commercial Officer Mr. Tyler Van HornVP of Corporate Strategy & Chief of StaffMore ExecutivesKey CompetitorsForianNASDAQ:FORAProtara TherapeuticsNASDAQ:TARAModular MedicalNASDAQ:MODDAkuminNASDAQ:AKUMQLianBioNASDAQ:LIANView All CompetitorsInstitutional OwnershipKent Lake Capital LLCSold 805,911 shares on 2/14/2024Ownership: 4.666%Boston PartnersSold 1,384,183 shares on 2/7/2024Ownership: 0.664%Glynn Capital Management LLCSold 3,362,832 shares on 2/6/2024Ownership: 2.965%Russell Investments Group Ltd.Sold 3,794,839 shares on 2/5/2024Ownership: 2.842%View All Institutional Transactions SNCE Stock Analysis - Frequently Asked Questions Should I buy or sell Science 37 stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Science 37 in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SNCE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNCE, but not buy additional shares or sell existing shares. View SNCE analyst ratings or view top-rated stocks. When did Science 37's stock split? Science 37 shares reverse split on Friday, December 8th 2023. The 1-20 reverse split was announced on Friday, December 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, December 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. This page (NASDAQ:SNCE) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Science 37 Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
